Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.

Show other versions (1)

The differences in incidence rates of Haemophilus influenzae type b disease and the variation in Hib conjugate vaccine efficacy achieved among different ethnic groups suggest genetic influences on the immune response to Hib vaccine. The serum anti-PRP antibody concentration of 43 monozygotic (MZ) an...

Bibliografske podrobnosti
Main Authors:	Lee, Y, Newport, M, Goetghebuer, T, Siegrist, C, Weiss, H, Pollard, A, Marchant, A
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
od: Lee, Y, et al.
Izdano: (2006)

Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study
od: Kusnandi Rusmil, et al.
Izdano: (2013-12-01)

Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.
od: Chris Finan, et al.
Izdano: (2008-01-01)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
od: Zhen-jiang LIU, et al.
Izdano: (2022-02-01)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
od: Yuntao Zhang, et al.
Izdano: (2022-12-01)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
od: Sanjay K. Lalwani, et al.
Izdano: (2017-01-01)

Immunogenicity and Reactogenicity of DTPa-IPV/Hib Vaccine Co-administered With Hepatitis B Vaccine for Primary and Booster Vaccination of Taiwanese Infants
od: Pei-Lan Shao, et al.
Izdano: (2011-06-01)

Hib Vaccines: Past, Present, and Future Perspectives
od: Adi Essam Zarei, et al.
Izdano: (2016-01-01)

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
od: Imoukhuede, E, et al.
Izdano: (2006)

Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population.
od: Bowdish, D, et al.
Izdano: (2013)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
od: Ota, M, et al.
Izdano: (2011)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
od: Ota, M, et al.
Izdano: (2011)

Safety and immunogenicity of malaria vectored vaccines given with routine EPI vaccines in Gambian infants and neonates: a randomized controlled trial
od: Mensah, V, et al.
Izdano: (2017)

Global Hib vaccination: reasons to cheer and fear
od: Stephen R C Howie
Izdano: (2016-03-01)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
od: Andrea Guerra, et al.
Izdano: (2024-12-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
od: L. S. Namazova-Baranova, et al.
Izdano: (2019-06-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
od: Marissa B. Wilck, et al.
Izdano: (2021-01-01)

Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India
od: Ashish Bavdekar, et al.
Izdano: (2019-06-01)

Occurrence of Haemophilus influenzae type b (Hib) meningitis in a 2 month-old infant in the Hib vaccination era
od: Yoshiaki Cho, et al.
Izdano: (2022-06-01)

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule
od: Collard Alix, et al.
Izdano: (2010-10-01)

Lagging Immune Response to <i>Haemophilus influenzae</i> Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
od: Leo Schouls, et al.
Izdano: (2020-06-01)

Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
od: Victorine A. Mensah, et al.
Izdano: (2017-11-01)

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
od: Hitt Sharma, et al.
Izdano: (2024-02-01)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
od: Moorthy, V, et al.
Izdano: (2004)

Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
od: D.C.S. Matos, et al.
Izdano: (2009-12-01)

VACCINATION AGAINST FLU, PNEUMOCOCCAL, MENINGOCOCCAL AND HIB INFECTION OF THE SICKLY CHILDREN
od: L.S. Namazova, et al.
Izdano: (2007-02-01)

VACCINATION AGAINST FLU, PNEUMOCOCCAL, MENINGOCOCCAL AND HIB INFECTION OF THE SICKLY CHILDREN
od: L.S. Namazova, et al.
Izdano: (2007-02-01)

Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.
od: McVernon, J, et al.
Izdano: (2008)

Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages [version 1; peer review: 2 approved]
od: David Jeffries, et al.
Izdano: (2024-12-01)

Real-time stability of the Ecuadorian pentavalent DTP-HB-Hib vaccine
od: Néstor Expósito, et al.

Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants
od: Moore Sophie E, et al.
Izdano: (2008-05-01)

The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months
od: Yu-Xiao Wang, et al.
Izdano: (2017-05-01)

Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
od: Naveena Aloysia D'Cor, et al.
Izdano: (2023-01-01)

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.
od: Khatami, A, et al.
Izdano: (2013)

SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS
od: I. V. Feldblyum, et al.
Izdano: (2016-02-01)

Phacomorphic glaucoma in Gambians
od: Chimdi M Chuka - Okosa
Izdano: (2003-01-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
od: Ki Hwan Kim, et al.
Izdano: (2019-02-01)

Immunogenicity and safety of DTPW-HEPB-HIB (PRP-T) vaccine (Pentavac) in infants aged 2–7 months: a post marketing phase 4 clinical trial study
od: H. Masoumi-Asl, et al.
Izdano: (2024-10-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
od: Irina V. Mikheeva, et al.
Izdano: (2019-09-01)

Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa
od: A von Gottberg, et al.
Izdano: (2006-10-01)